 Adrenergic beta-1 Receptor Antagonists
"Adrenergic beta-1 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS.
| Descriptor ID |
D058671
|
| MeSH Number(s) |
D27.505.519.625.050.200.200.100 D27.505.696.577.050.200.200.100
|
| Concept/Terms |
Adrenergic beta-1 Receptor Antagonists- Adrenergic beta-1 Receptor Antagonists
- Adrenergic beta 1 Receptor Antagonists
- Adrenergic beta1-Antagonists
- Adrenergic beta1 Antagonists
- beta1-Antagonists, Adrenergic
- beta-1 Adrenergic Blocking Agents
- beta 1 Adrenergic Blocking Agents
- Adrenergic beta-1 Antagonists
- Adrenergic beta 1 Antagonists
- Antagonists, Adrenergic beta-1
- beta-1 Antagonists, Adrenergic
- Adrenergic beta-1 Receptor Blockers
- Adrenergic beta 1 Receptor Blockers
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-1 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-1 Receptor Antagonists".
This graph shows the total number of publications written about "Adrenergic beta-1 Receptor Antagonists" by people in this website by year, and whether "Adrenergic beta-1 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2013 | 1 | 1 | 2 | | 2017 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-1 Receptor Antagonists" by people in Profiles.
-
Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoglu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE. Metoprolol for the Prevention of Acute Exacerbations of COPD. N Engl J Med. 2019 12 12; 381(24):2304-2314.
-
Parikh KS, Fiuzat M, Davis G, Neely M, Blain-Nelson P, Whellan DJ, Abraham WT, Adams KF, Felker GM, Liggett SB, O'Connor CM, Bristow MR. Dose Response of ?-Blockers in Adrenergic Receptor Polymorphism Genotypes. Circ Genom Precis Med. 2018 08; 11(8):e002210.
-
Stauffer BL, Dow CA, Diehl KJ, Bammert TD, Greiner JJ, DeSouza CA. Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure. J Am Heart Assoc. 2017 Nov 09; 6(11).
-
Sucharov CC, Hijmans JG, Sobus RD, Melhado WF, Miyamoto SD, Stauffer BL. ?-Adrenergic receptor antagonism in mice: a model for pediatric heart disease. J Appl Physiol (1985). 2013 Oct 01; 115(7):979-87.
-
Lundgrin EL, Park MM, Sharp J, Tang WH, Thomas JD, Asosingh K, Comhair SA, DiFilippo FP, Neumann DR, Davis L, Graham BB, Tuder RM, Dostanic I, Erzurum SC. Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. Ann Am Thorac Soc. 2013 Feb; 10(1):1-9.
-
Bristow MR. Mechanistic and clinical rationales for using beta-blockers in heart failure. J Card Fail. 2000 Jun; 6(2 Suppl 1):8-14.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|